Full-Time

Clinical Research Associate

Confirmed live in the last 24 hours

Orca Bio

Orca Bio

51-200 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Mid

Remote in USA

Can be based anywhere in the U.S., west coast preferred.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Google Cloud Platform
Requirements
  • BA/BS or equivalent with a minimum of 3+ years of relevant clinical trial management experience
  • Therapeutic experience in oncology/hematology and cell and gene therapy preferred
  • Prior CRA experience working directly for sponsor, ideally a start-up/or small company, in a co-monitoring capacity
  • Strong working knowledge of FDA and ICH/GCP regulations and guidelines and thorough knowledge of clinical monitoring procedures
  • Experience with Trial Master File management according to the DIA reference model
  • Experience operating within various site EMR/EHR systems
  • Experience using eTMF, EDC (IBM Zelta experience ideal), CTMS, and other vendors systems/portals
Responsibilities
  • Conduct interim monitoring visits (IMVs) and ISF review
  • Review electronic medical records (EMR)/patient data
  • Source documentation verification (SDV) against case report form data, including informing the site staff of any entry errors, ensuring good documentation practices are being adhered to and communicating protocol deviations appropriately per SOPs, GCP and applicable regulatory requirements
  • Verification and review of adverse events, serious adverse events, concomitant medications and corresponding illnesses to confirm accurate data reporting in accordance with the protocol
  • Provide support to site staff including research coordinators and physicians
  • Assist in the development of trial materials as needed (e.g., case report forms, monitoring guidelines, site tools and training guides)
  • Contribute to the development of Clinical Operations SOPs, best practices, work instructions, tools and templates

Orca Bio operates in the biotechnology field, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently lack effective treatments.

Company Stage

Series D

Total Funding

$186.8M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

12%

1 year growth

16%

2 year growth

42%
Simplify Jobs

Simplify's Take

What believers are saying

  • Orca-T shows promising relapse-free survival rates in hematologic malignancies.
  • The FDA's fast-tracking of cell therapy approvals supports Orca Bio's innovative treatments.
  • Orca Bio's therapies align with the trend towards value-based healthcare.

What critics are saying

  • Competition from companies like BlueRock Therapeutics challenges Orca Bio's market position.
  • Rapid advancements by Aspen Neuroscience pose a competitive threat to Orca Bio.
  • Emerging autologous iPSC-derived therapies could overshadow Orca Bio's offerings.

What makes Orca Bio unique

  • Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
  • The company uses single-cell precision to create uniquely-defined cell therapy products.
  • Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Help us improve and share your feedback! Did you find this helpful?